Literature DB >> 26701376

Cognitive functioning of patients with a PRL-secreting pituitary adenoma: A preliminary report.

Aleksandra Bala1, Emilia Łojek2, Andrzej Marchel2.   

Abstract

OBJECTIVE: The aim of this study was to evaluate cognitive functions in patients with prolactin (PRL)-secreting pituitary adenoma.
METHODS: We conducted a hospital-based case-control study. The effect of PRL overproduction on cognitive processes was assessed with a comprehensive battery of neuropsychological tests to measure verbal memory, nonverbal memory, attention, visuospatial skills, verbal fluency, and executive functions. The data were gathered from 40 participants matched for age, sex, handedness, and education (20 with pituitary adenoma, 20 healthy controls). The patients were examined on the first day of their hospitalization in the Department of Neurosurgery of Medical University of Warsaw. MRI as well as blood test of pituitary hormone level and perimetry test of the visual field were conducted.
RESULTS: The group of patients had significantly lower scores on verbal memory, nonverbal memory, and attention tests compared with healthy volunteers. Their results in memory and visuospatial tests were significantly negatively correlated with the level of PRL but there was no marked relationship between cognitive functioning and the size of tumor.
CONCLUSIONS: This study demonstrated a significant relationship between PRL overproduction and worsening of cognitive processes, especially in the domains of memory and attention in hospitalized patients with pituitary adenomas. Greater hyperprolactinemia was associated with a larger decrease in cognitive performance. There was no effect of tumor size.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Year:  2015        PMID: 26701376     DOI: 10.1212/WNL.0000000000002252

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.

Authors:  Meritxell Tost; José Antonio Monreal; Antonio Armario; Juan David Barbero; Jesús Cobo; Clemente García-Rizo; Miquel Bioque; Judith Usall; Elena Huerta-Ramos; Virginia Soria; Javier Labad
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

2.  Predictive value of T2 relative signal intensity for response to somatostatin analogs in newly diagnosed acromegaly.

Authors:  Ming Shen; Qilin Zhang; Wenjuan Liu; Meng Wang; Jingjing Zhu; Zengyi Ma; Wenqiang He; Shiqi Li; Xuefei Shou; Yiming Li; Zhaoyun Zhang; Hongying Ye; Min He; Bin Lu; Zhenwei Yao; Yun Lu; Nidan Qiao; Zhao Ye; Yichao Zhang; Yeping Yang; Yao Zhao; Yongfei Wang
Journal:  Neuroradiology       Date:  2016-08-11       Impact factor: 2.804

3.  The impact on cognitive functions of patients with pituitary adenoma before and after surgery.

Authors:  Xianxiang Wang; Xuanxia Tong; Yanfeng Zou; Xuefeng Tian; Zhongxiang Mao; Zhongwu Sun
Journal:  Neurol Sci       Date:  2017-05-06       Impact factor: 3.307

4.  Hormone levels are related to functional compensation in prolactinomas: A resting-state fMRI study.

Authors:  Shun Yao; Pan Lin; Matthew Vera; Farhana Akter; Ru-Yuan Zhang; Ailiang Zeng; Alexandra J Golby; Guozheng Xu; Yanmei Tie; Jian Song
Journal:  J Neurol Sci       Date:  2020-02-01       Impact factor: 3.181

5.  Cognitive Function and Serum Hormone Levels Are Associated with Gray Matter Volume Decline in Female Patients with Prolactinomas.

Authors:  Shun Yao; Jian Song; Junfeng Gao; Pan Lin; Ming Yang; Kashif Rafiq Zahid; Yan Yan; Chenglong Cao; Pan Ma; Hui Zhang; Zhouyue Li; Cheng Huang; Huichao Ding; Guozheng Xu
Journal:  Front Neurol       Date:  2018-01-29       Impact factor: 4.003

6.  Theta oscillations in prolactinomas: Neurocognitive deficits in executive controls.

Authors:  Chenglong Cao; Wen Wen; Binbin Liu; Pan Ma; Sheng Li; Guozheng Xu; Jian Song
Journal:  Neuroimage Clin       Date:  2020-09-30       Impact factor: 4.881

7.  Hyperprolactinemia Associated with Attentional Processing and Interference Control Impairments in Patients with Prolactinomas.

Authors:  Aobo Chen; Chenglong Cao; Bangxin Liu; Shuochen Wang; Shukai Wu; Guozheng Xu; Jian Song
Journal:  Brain Sci       Date:  2022-08-17

8.  Prolactin Reduces Hippocampal Parvalbumin and GABAA Receptor Expression in Female Mice.

Authors:  Susana Mellado; Beatriz Moreno-Ruiz; Sara Expósito; Miriam Fernández; Eduardo D Martín
Journal:  Neuroendocrinology       Date:  2021-10-19       Impact factor: 5.135

9.  Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants.

Authors:  Merel van der Meulen; Amir H Zamanipoor Najafabadi; Daniel J Lobatto; Wilbert B van den Hout; Cornelie D Andela; Ingrid M Zandbergen; Alberto M Pereira; Wouter R van Furth; Thea P M Vliet Vlieland; Nienke R Biermasz
Journal:  Pituitary       Date:  2020-10-06       Impact factor: 4.107

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.